SCHEMBL435318

SCHEMBL435318

N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 7/20 0.62
▸ NAALAD2 Q9Y3Q0 4/20 0.62
▸ RIMKLA Q8IXN7 1/20 0.62
▸ DPP4 P27487 1/20 0.57
▸ DPP8 Q6V1X1 1/20 0.57
▸ DPP9 Q86TI2 1/20 0.57
▸ GRM8 O00222 1/20 0.57
▸ GRM6 O15303 1/20 0.57
▸ GRIN2D O15399 1/20 0.57
▸ GRIN3B O60391 1/20 0.57
▸ GSR P00390 1/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ GRIK1 P39086 1/20 0.57
▸ GRM5 P41594 1/20 0.57
▸ GRIA1 P42261 1/20 0.57
▸ GRIA2 P42262 1/20 0.57
▸ GRIA3 P42263 1/20 0.57
▸ SLC1A3 P43003 1/20 0.57
▸ SLC1A2 P43004 1/20 0.57
▸ SLC1A1 P43005 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2710756 1.00 FOLH1 (0.62) FOLH1NAALAD2RIMKLADPP4DPP8
SCHEMBL435319 1.00 FOLH1 (0.62) FOLH1NAALAD2RIMKLADPP4DPP8
SCHEMBL27956852 1.00 FOLH1 (0.62) FOLH1NAALAD2RIMKLADPP4DPP8
SCHEMBL8382463 1.00 FOLH1 (0.62) FOLH1NAALAD2RIMKLADPP4DPP8
SCHEMBL7923681 1.00 FOLH1 (0.62) FOLH1NAALAD2RIMKLADPP4DPP8
SCHEMBL28486006 0.98 FOLH1 (0.60) FOLH1NAALAD2RIMKLADPP4DPP8
SCHEMBL28486008 0.98 FOLH1 (0.60) FOLH1NAALAD2RIMKLADPP4DPP8
SCHEMBL22111146 0.96 FOLH1 (0.58) FOLH1NAALAD2RIMKLADPP4DPP8
SCHEMBL20739235 0.96 FOLH1 (0.58) FOLH1NAALAD2RIMKLADPP4DPP8
SCHEMBL20739236 0.96 FOLH1 (0.58) FOLH1NAALAD2RIMKLADPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2223 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122029186-A Human growth hormone receptor antagonists and methods of use thereof OPKO生物科学有限公司 2026-05-12 — — CN claimed
EP-4729561-A1 POLYETHYLENE GLYCOL DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF Chongqing Upgra Biotechnology Co., Ltd. (CN) 2026-04-22 — — EP claimed
US-20260076970-A1 CANCER TREATMENT USING MTDP INHIBITORS AND PLK1 INHIBITORS CARDIFF ONCOLOGY INC (US) 2026-03-19 — — US claimed
US-20260034090-A1 CANNABINOID PRODRUG COMPOUNDS FIRSTLIGHT PHARMACEUTICALS LLC (US) 2026-02-05 — — US claimed
EP-4683931-A1 PARVOVIRUS COMPOSITIONS AND RELATED METHODS FOR GENE THERAPY Carbon Biosciences, Inc. (US) 2026-01-28 — — EP claimed
EP-4679087-A1 BIOMARKER AND USE THEREOF MEIJI CO., LTD (JP) 2026-01-14 — — EP claimed
EP-4659592-A1 FLAVOR ENHANCING COMPOSITION, MANUFACTURING METHOD THEREFOR, AND METHOD FOR ENHANCING FLAVOR OF FOOD PRODUCT House Foods Corporation (JP) 2025-12-10 — — EP claimed
EP-4659591-A1 TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT House Foods Group Inc. (JP) 2025-12-10 — — EP claimed
EP-4634214-A1 SYNTHETIC ACTIVATION OF MULTIMERIC TRANSMEMBRANE RECEPTORS Aarhus Universitet (DK) 2025-10-22 — — EP claimed
WO-2025213250-A1 ENZYMATIC COMPOSITIONS FOR B ANTIGEN CLEAVAGE, METHODS, USES, APPARATUSES AND SYSTEMS ASSOCIATED THEREWITH THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2025-10-16 — — WO claimed
CN-113956348-A Glucagon and GLP-1 co-agonist compounds 伊莱利利公司 2022-01-21 — — CN claimed
US-20160282351-A1 SALIVARY BIOMARKERS FOR CANCERS, METHODS AND DEVICES FOR ASSAYING THE SAME, AND METHODS FOR DETERMINING SALIVARY BIOMARKERS FOR CANCERS SALIVATECH CO., LTD. (JP) 2016-09-29 — — US claimed
EP-3064940-A1 SALIVARY BIOMARKER FOR CANCER, METHOD AND DEVICE FOR ASSAYING SAME, AND METHOD FOR DETERMINING SALIVARY BIOMARKER FOR CANCER Salivatech Co., Ltd. (JP) 2016-09-07 — — EP claimed
CN-105683390-A HbA1c measurement method using amadoriase acting on glycated peptides 龟甲万株式会社 2016-06-15 — — CN claimed
EP-2661266-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES Elcelyx Therapeutics, Inc. (US) 2013-11-13 — — EP claimed
WO-2012094636-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES ELCELYX THERAPEUTICS, INC. (US) 2012-07-12 — — WO claimed
WO-2012010851-A1 CAPILLARY ELECTROPHORESIS OF CARBOHYDRATES CAMBRIDGE ENTERPRISE LIMITED (GB) 2012-01-26 — — WO claimed
JP-H09510696-A — — 1997-10-28 — — JP claimed
EP-0737077-A1 HEPATOCYTE-TARGETED DRUG CONJUGATES TARGETECH, INC. (US) 1996-10-16 — — EP claimed
WO-1995018636-A2 HEPATOCYTE-TARGETED DRUG CONJUGATES TARGETECH INC (US) 1995-07-13 — — WO claimed
Send feedback